Buhmann C - Search Results

1

Role of dopamine agonists in Parkinson's disease therapy.

Woitalla D, Buhmann C, Hilker-Roggendorf R, Höglinger G, Koschel J, Müller T, Weise D. Woitalla D, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2023 Jun;130(6):863-873. doi: 10.1007/s00702-023-02647-0. Epub 2023 May 11. J Neural Transm (Vienna). 2023. PMID: 37165120 Review.

2

Wearable sensor-based objective assessment of motor symptoms in Parkinson's disease.

Ossig C, Antonini A, Buhmann C, Classen J, Csoti I, Falkenburger B, Schwarz M, Winkler J, Storch A. Ossig C, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2016 Jan;123(1):57-64. doi: 10.1007/s00702-015-1439-8. Epub 2015 Aug 8. J Neural Transm (Vienna). 2016. PMID: 26253901 Review.

3

[Parkinson's Disease at the Border Between Inpatient and Outpatient Care].

Buhmann C, Bass H, Hahne M, Jost W, Redecker C, Schwarz M, Woitalla D. Buhmann C, et al. Fortschr Neurol Psychiatr. 2016 Jul;84 Suppl 1:S36-40. doi: 10.1055/s-0042-103325. Epub 2016 Jun 8. Fortschr Neurol Psychiatr. 2016. PMID: 27276071 Review. German.

4

Levodopa/carbidopa intestinal gel (LCIG) infusion as mono- or combination therapy.

Buhmann C, Hilker R, Lingor P, Schrader C, Schwarz J, Wolz M, Reichmann H. Buhmann C, et al. J Neural Transm (Vienna). 2017 Aug;124(8):1005-1013. doi: 10.1007/s00702-017-1698-7. Epub 2017 Feb 22. J Neural Transm (Vienna). 2017. PMID: 28229223

5

Evidence for the use of cannabinoids in Parkinson's disease.

Buhmann C, Mainka T, Ebersbach G, Gandor F. Buhmann C, et al. J Neural Transm (Vienna). 2019 Jul;126(7):913-924. doi: 10.1007/s00702-019-02018-8. Epub 2019 May 27. J Neural Transm (Vienna). 2019. PMID: 31131434 Review.

6

Discussing sexuality with Parkinson's disease patients: a multinational survey among neurologists.

de Rooy FBB, Buhmann C, Schönwald B, Martinez-Martin P, Rodriguez-Blazquez C, Putter H, Elzevier HW, van der Plas AA. de Rooy FBB, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2019 Oct;126(10):1273-1280. doi: 10.1007/s00702-019-02053-5. Epub 2019 Aug 8. J Neural Transm (Vienna). 2019. PMID: 31396705 Free PMC article.

7

[Recommendation for the differentiated use of nuclear medical diagnostic for parkinsonian syndromes].

van Eimeren T, Claßen J, Drzezga A, Eggers C, Hilker-Roggendorf R, Klucken J, Koschel J, Meyer PT, Redecker C, Theis H, Buhmann C. van Eimeren T, et al. Among authors: buhmann c. Fortschr Neurol Psychiatr. 2020 Sep;88(9):609-619. doi: 10.1055/a-1207-0515. Epub 2020 Sep 21. Fortschr Neurol Psychiatr. 2020. PMID: 32957144 Review. German.

8

[Relevance of COMT inhibitors in the treatment of motor fluctuations].

Jost WH, Buhmann C, Classen J, Eggert K, Kohl Z, Outeiro T, Tönges L, Woitalla D, Reichmann H. Jost WH, et al. Among authors: buhmann c. Nervenarzt. 2022 Oct;93(10):1035-1045. doi: 10.1007/s00115-021-01237-3. Epub 2022 Jan 19. Nervenarzt. 2022. PMID: 35044481 Review. German.

9

Blood-based biomarker in Parkinson's disease: potential for future applications in clinical research and practice.

Tönges L, Buhmann C, Klebe S, Klucken J, Kwon EH, Müller T, Pedrosa DJ, Schröter N, Riederer P, Lingor P. Tönges L, et al. Among authors: buhmann c. J Neural Transm (Vienna). 2022 Sep;129(9):1201-1217. doi: 10.1007/s00702-022-02498-1. Epub 2022 Apr 15. J Neural Transm (Vienna). 2022. PMID: 35428925 Free PMC article. Review.

10

Blood neurofilament light chain in Parkinson's disease.

Buhmann C, Magnus T, Choe CU. Buhmann C, et al. J Neural Transm (Vienna). 2023 Jun;130(6):755-762. doi: 10.1007/s00702-023-02632-7. Epub 2023 Apr 17. J Neural Transm (Vienna). 2023. PMID: 37067597 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

164 results

Search Page